Makers Laboratories achieved a significant financial turnaround in the December 2025 quarter, reporting a consolidated net profit of ₹0.94 crore compared to a net loss of ₹0.30 crore in the corresponding quarter of the previous year. According to reports from Business Standard, this represents a complete reversal of the company's financial performance, marking a substantial improvement in operational efficiency and profitability.
The company demonstrated strong revenue momentum with sales rising 28.82% to ₹35.67 crore in Q3 FY26, as reported by Business Standard. This compares favorably to the sales of ₹27.69 crore recorded in the December 2024 quarter, indicating robust demand for the company's products and services. The substantial revenue growth contributed significantly to the overall improvement in financial performance.
Operating profit margin (OPM) improved to 11.66% in the December 2025 quarter from 4.73% in the previous year, as reported by Business Standard. The company's PBDT (Profit Before Depreciation and Tax) increased by 116% to ₹4.29 crore from ₹1.99 crore in the corresponding quarter of the previous year. Additionally, PBT (Profit Before Tax) surged by 363% to ₹3.15 crore compared to ₹0.68 crore in December 2024.
